Integra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.65, $0.04 better than the analyst estimate of $0.61. Revenue for the quarter came in at $359.7 million versus the consensus estimate of $360.38 million.

GUIDANCE:

Integra LifeSciences sees FY2019 EPS of $2.65-$2.72, versus the consensus of $2.69. Integra LifeSciences sees FY2019 revenue of $1.515-1.525 billion, versus the consensus of $1.52 billion.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.